89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts
89bio, Inc. (NASDAQ:ETNB – Get Free Report) has been assigned an average rating of “Buy” from the nine research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and two have given a strong buy recommendation to the […]
89bio, Inc. (NASDAQ:ETNB – Get Free Report) has been assigned an average rating of “Buy” from the nine research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and two have given a strong buy recommendation to the […]
